Myungmoon Ceftriaxone Sodium Hydrate Injection 1g

Adult administration

Adults and children over 12 years: administer 1-2 g (dosage) of ceftriaxone once daily via intravenous or intramuscular injection. For infections caused by severe pathogens or pathogens with moderate susceptibility, the dose can be increased to 4 g (dosage) once daily. A single intramuscular injection of 250 mg (dosage) is recommended for the treatment of gonorrhea. To prevent infections before and after surgery, administer 1-2 g (dosage) once 30-90 minutes before surgery. For the elderly

Child administration

Neonates (within 14 days of birth): administer 20-50 mg (dosage) per kg of body weight once a day, not exceeding 50 mg (dosage) per kg of body weight. Infants and children (from 15 days to 12 years): body

This drug should not be used with solutions containing calcium. In particular, it should not be administered to newborns as there is a risk of precipitation when calcium meets this drug. Patients allergic to this drug or who have had hypersensitivity reactions to other specific antibiotics should not use this medication. This drug should also not be given to premature infants or newborns with bilirubin-related problems. Patients with impaired kidney function or a history of allergies should use this drug cautiously. It is important to regularly monitor liver and kidney function, as well as blood status, during treatment. If any abnormal symptoms such as rash, hives, difficulty breathing, or severe diarrhea appear during treatment, treatment should be stopped immediately, and a doctor should be consulted. Care should be taken when driving or operating machinery due to potential side effects like dizziness. Women who are pregnant or breastfeeding should make careful decisions about using this drug after consultation with a physician. Older adults may experience side effects more readily due to decreased physical function, so dosage and administration intervals should be adjusted, and careful observation is necessary. This drug may interact with other medications; therefore, it is crucial to inform healthcare providers, especially when taken with calcium preparations, diuretics, or aminoglycoside antibiotics. Prepared medication should be used as soon as possible, and it is important to manage storage at appropriate temperatures.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, high fever with severe rash, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• increased platelets
• agranulocytosis
• anemia
• hemolytic anemia

This drug should be stored in a sealed container to prevent air or moisture from entering. It is best to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage can help maintain the drug's effectiveness.

Appearance

[For domestic use] A vial filled with white to pale yellow crystalline powder [For export] A colorless, transparent vial containing white to pale yellow powder.

Package unit

1 vial x 10